Integra LifeSciences Holdings Corporation

69.92+0.4800+0.69%Vol 173.47K1Y Perf 45.16%
Apr 13th, 2021 16:00 DELAYED
BID69.92 ASK70.04
Open68.99 Previous Close69.44
Pre-Market- After-Market69.92
 - -  - -%
Target Price
65.67 
Analyst Rating
Moderate Buy 2.42
Potential %
-6.08 
Finscreener Ranking
★+     44.29
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★     48.20
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★+     55.13
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Market Cap5.90B 
Earnings Rating
Sell
Price Range Ratio 52W %
95.14 
Earnings Date
28th Apr 2021

Today's Price Range

67.6370.31

52W Range

42.1271.34

5 Year PE Ratio Range

-912.50116.00

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
2.70%
1 Month
2.67%
3 Months
3.16%
6 Months
46.06%
1 Year
45.16%
3 Years
26.51%
5 Years
109.81%
10 Years
191.45%

TickerPriceChg.Chg.%
IART69.920.48000.69
AAPL134.433.19002.43
GOOG2 267.2712.48000.55
MSFT258.312.40000.94
XOM55.710.21000.38
WFC39.79-0.9800-2.40
JNJ159.48-2.1600-1.34
FB309.76-1.7800-0.57
GE13.44-0.1500-1.10
JPM154.09-1.8600-1.19
Earnings HistoryEstimateReportedSurprise %
Q04 20200.740.8413.51
Q03 20200.570.8040.35
Q02 20200.080.33312.50
Q01 20200.600.48-20.00
Q04 20190.670.681.49
Q03 20190.650.684.62
Q02 20190.650.7312.31
Q01 20190.610.656.56
Earnings Per EndEstimateRevision %Trend
3/2021 QR0.56-12.50Negative
6/2021 QR0.68-1.45Negative
12/2021 FY2.89-0.34Negative
12/2022 FY3.291.23Positive
Next Report Date28th Apr 2021
Estimated EPS Next Report0.56
Estimates Count7
EPS Growth Next 5 Years %13.20
Volume Overview
Volume173.47K
Shares Outstanding84.37M
Trades Count4.01K
Dollar Volume38.90M
Avg. Volume368.58K
Avg. Weekly Volume321.53K
Avg. Monthly Volume328.12K
Avg. Quarterly Volume367.90K

Integra LifeSciences Holdings Corporation (NASDAQ: IART) stock closed at 69.92 per share at the end of the most recent trading day (a 0.69% change compared to the prior day closing price) with a volume of 278.80K shares and market capitalization of 5.90B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 3700 people. Integra LifeSciences Holdings Corporation CEO is Peter J. Arduini.

The one-year performance of Integra LifeSciences Holdings Corporation stock is 45.16%, while year-to-date (YTD) performance is 7.7%. IART stock has a five-year performance of 109.81%. Its 52-week range is between 42.12 and 71.34, which gives IART stock a 52-week price range ratio of 95.14%

Integra LifeSciences Holdings Corporation currently has a PE ratio of 44.10, a price-to-book (PB) ratio of 3.87, a price-to-sale (PS) ratio of 5.77, a price to cashflow ratio of 29.00, a PEG ratio of 2.32, a ROA of 3.71%, a ROC of 3.25% and a ROE of 8.76%. The company’s profit margin is 12.63%, its EBITDA margin is 20.50%, and its revenue ttm is $1.02 Billion , which makes it $12.04 revenue per share.

Of the last four earnings reports from Integra LifeSciences Holdings Corporation, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.56 for the next earnings report. Integra LifeSciences Holdings Corporation’s next earnings report date is 28th Apr 2021.

The consensus rating of Wall Street analysts for Integra LifeSciences Holdings Corporation is Moderate Buy (2.42), with a target price of $65.67, which is -6.08% compared to the current price. The earnings rating for Integra LifeSciences Holdings Corporation stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Integra LifeSciences Holdings Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Integra LifeSciences Holdings Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 7.57, ATR14 : 2.50, CCI20 : 104.90, Chaikin Money Flow : 0.08, MACD : 0.12, Money Flow Index : 46.46, ROC : 5.72, RSI : 46.25, STOCH (14,3) : 89.59, STOCH RSI : 0.76, UO : 67.40, Williams %R : -10.41), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Integra LifeSciences Holdings Corporation in the last 12-months were: Daniel L. Reuvers (Option Excercise at a value of $862 601), Daniel L. Reuvers (Sold 23 330 shares of value $1 226 925 ), Eric I. Schwartz (Sold 6 500 shares of value $450 092 ), Glenn G. Coleman (Sold 22 000 shares of value $1 186 735 ), Jeffrey A. Mosebrook (Sold 1 865 shares of value $114 393 ), Jeffrey Mosebrook (Sold 1 614 shares of value $83 418 ), Lisa Evoli (Option Excercise at a value of $255 627), Lisa Evoli (Sold 18 155 shares of value $978 277 ), Michael McBreen (Sold 2 205 shares of value $152 145 ), Peter J. Arduini (Option Excercise at a value of $1 070 341), Peter J. Arduini (Sold 67 786 shares of value $4 296 222 ), Raymond G. Murphy (Sold 2 839 shares of value $150 921 ), Richard E. Caruso (Option Excercise at a value of $432 525), Richard E. Caruso (Sold 600 000 shares of value $29 082 000 ), Robert T. Davis (Sold 24 941 shares of value $1 732 963 ), Stuart M. Essig (Sold 514 551 shares of value $30 260 146 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (33.33 %)
4 (36.36 %)
2 (20.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
7 (58.33 %)
6 (54.55 %)
7 (70.00 %)
Moderate Sell
1 (8.33 %)
1 (9.09 %)
1 (10.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.42
Moderate Buy
2.36
Hold
2.70

Integra LifeSciences Holdings Corporation

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and orthopedics and tissue technologies. Codman specialty surgical generates maximum revenue from its segmental operations. Integra earns approximately 29% of sales internationally, with the remainder 71% derived from the United States.

CEO: Peter J. Arduini

Telephone: +1 609 275-0500

Address: 1100 Campus Road, Princeton 08540, NJ, US

Number of employees: 3 700

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

54%46%

Bearish Bullish

50%50%

News

Stocktwits